These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 38399728)

  • 1. Changes in Bacterial Gut Composition in Parkinson's Disease and Their Metabolic Contribution to Disease Development: A Gut Community Reconstruction Approach.
    Forero-Rodríguez J; Zimmermann J; Taubenheim J; Arias-Rodríguez N; Caicedo-Narvaez JD; Best L; Mendieta CV; López-Castiblanco J; Gómez-Muñoz LA; Gonzalez-Santos J; Arboleda H; Fernandez W; Kaleta C; Pinzón A
    Microorganisms; 2024 Feb; 12(2):. PubMed ID: 38399728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson's disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions.
    Baldini F; Hertel J; Sandt E; Thinnes CC; Neuberger-Castillo L; Pavelka L; Betsou F; Krüger R; Thiele I;
    BMC Biol; 2020 Jun; 18(1):62. PubMed ID: 32517799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's Disease and the Gut Microbiome in Rural California.
    Zhang K; Paul KC; Jacobs JP; Chou HL; Duarte Folle A; Del Rosario I; Yu Y; Bronstein JM; Keener AM; Ritz B
    J Parkinsons Dis; 2022; 12(8):2441-2452. PubMed ID: 36442206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Microbiota and Metabolome Alterations Associated with Parkinson's Disease.
    Vascellari S; Palmas V; Melis M; Pisanu S; Cusano R; Uva P; Perra D; Madau V; Sarchioto M; Oppo V; Simola N; Morelli M; Santoru ML; Atzori L; Melis M; Cossu G; Manzin A
    mSystems; 2020 Sep; 5(5):. PubMed ID: 32934117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson's disease.
    Cui C; Han Y; Li H; Yu H; Zhang B; Li G
    Front Cell Infect Microbiol; 2022; 12():887407. PubMed ID: 36034698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease.
    Cirstea MS; Yu AC; Golz E; Sundvick K; Kliger D; Radisavljevic N; Foulger LH; Mackenzie M; Huan T; Finlay BB; Appel-Cresswell S
    Mov Disord; 2020 Jul; 35(7):1208-1217. PubMed ID: 32357258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome.
    Hill-Burns EM; Debelius JW; Morton JT; Wissemann WT; Lewis MR; Wallen ZD; Peddada SD; Factor SA; Molho E; Zabetian CP; Knight R; Payami H
    Mov Disord; 2017 May; 32(5):739-749. PubMed ID: 28195358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiota-mediated effects of Parkinson's disease medications on Parkinsonian non-motor symptoms in male transgenic mice.
    Radisavljevic N; Metcalfe-Roach A; Cirstea M; Tabusi MM; Bozorgmehr T; Bar-Yoseph H; Finlay BB
    mSphere; 2024 Jan; 9(1):e0037923. PubMed ID: 38078745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of gut microbiota and metabolome with Parkinson's disease.
    Yan Z; Yang F; Cao J; Ding W; Yan S; Shi W; Wen S; Yao L
    Microb Pathog; 2021 Nov; 160():105187. PubMed ID: 34530073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-Omics Integration in Mice With Parkinson's Disease and the Intervention Effect of Cyanidin-3-
    Wang W; Zhu G; Wang Y; Li W; Yi S; Wang K; Fan L; Tang J; Chen R
    Front Aging Neurosci; 2022; 14():877078. PubMed ID: 35572129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Low-Protein, High-Carbohydrate Diet Exerts a Neuroprotective Effect on Mice with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinson's Disease by Regulating the Microbiota-Metabolite-Brain Axis and Fibroblast Growth Factor 21.
    Chu C; Li T; Yu L; Li Y; Li M; Guo M; Zhao J; Zhai Q; Tian F; Chen W
    J Agric Food Chem; 2023 Jun; 71(23):8877-8893. PubMed ID: 37267589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered gut microbiota in patients with idiopathic Parkinson's disease: an age-sex matched case-control study.
    Babacan Yildiz G; Kayacan ZC; Karacan I; Sumbul B; Elibol B; Gelisin O; Akgul O
    Acta Neurol Belg; 2023 Jun; 123(3):999-1009. PubMed ID: 36719617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of the Parkinson's disease gut microbiome suggests alterations linked to intestinal inflammation.
    Romano S; Savva GM; Bedarf JR; Charles IG; Hildebrand F; Narbad A
    NPJ Parkinsons Dis; 2021 Mar; 7(1):27. PubMed ID: 33692356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota in patients with Parkinson's disease in southern China.
    Lin A; Zheng W; He Y; Tang W; Wei X; He R; Huang W; Su Y; Huang Y; Zhou H; Xie H
    Parkinsonism Relat Disord; 2018 Aug; 53():82-88. PubMed ID: 29776865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal microbiome alterations in treatment-naive de novo Parkinson's disease.
    Boertien JM; Murtomäki K; Pereira PAB; van der Zee S; Mertsalmi TH; Levo R; Nojonen T; Mäkinen E; Jaakkola E; Laine P; Paulin L; Pekkonen E; Kaasinen V; Auvinen P; Scheperjans F; van Laar T;
    NPJ Parkinsons Dis; 2022 Oct; 8(1):129. PubMed ID: 36216843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiome in Parkinson's disease: New insights from meta-analysis.
    Toh TS; Chong CW; Lim SY; Bowman J; Cirstea M; Lin CH; Chen CC; Appel-Cresswell S; Finlay BB; Tan AH
    Parkinsonism Relat Disord; 2022 Jan; 94():1-9. PubMed ID: 34844021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls.
    Unger MM; Spiegel J; Dillmann KU; Grundmann D; Philippeit H; Bürmann J; Faßbender K; Schwiertz A; Schäfer KH
    Parkinsonism Relat Disord; 2016 Nov; 32():66-72. PubMed ID: 27591074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
    Chen R; Wang J; Zhan R; Zhang L; Wang X
    J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysbiosis of the Beneficial Gut Bacteria in Patients with Parkinson's Disease from India.
    Pavan S; Gorthi SP; Prabhu AN; Das B; Mutreja A; Vasudevan K; Shetty V; Ramamurthy T; Ballal M
    Ann Indian Acad Neurol; 2023; 26(6):908-916. PubMed ID: 38229613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease.
    Lai F; Jiang R; Xie W; Liu X; Tang Y; Xiao H; Gao J; Jia Y; Bai Q
    Neurochem Res; 2018 Oct; 43(10):1986-1999. PubMed ID: 30171422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.